Delivery Order SPE2DB20D1100-SPE2DB24FC3Z6

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,835.77 Delivery Order contract is for the supply of Pimecrolimus 1% Cream 30GM, a specialty pharmaceutical product, to support military healthcare programs. The contract has a completion date of January 29, 2025 and utilizes a Firm Fixed Price pricing type. This award is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, with a ceiling value of $1,322.25 and a period of performance through March 14, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,013.34 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream, a topical medication. The contract has an ultimate completion date of August 31, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,599.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PIMECROLIMUS 1% CREAM 30GM, a medical product, with a completion date of March 5, 2025. The contract is a Delivery Order and has a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.00 firm fixed-price delivery order is for the supply of PIMECROLIMUS 1% CREAM 30GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.65, is for the delivery of Pimecrolimus 1% Cream 100GM, a specialty pharmaceutical product. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,005.42, is a delivery order for the supply of PIMECROLIMUS 1% CREAM 60GM. The contract has a firm fixed price pricing type and an ultimate completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,205.52 firm fixed-price delivery order is for the supply of Pimecrolimus 1% Cream 30 GM, a prescription medication. The award is not associated with a set-aside program and represents an individual transaction under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,062.66, is for the delivery of Pimecrolimus 1% Cream 100GM, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Pimecrolimus 1% Cream 30GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,367.87 and was awarded on April 25, 2022, with an ultimate completion date of April 26, 2022. This is a firm fixed-price delivery order contract,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3Z6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of a pharmaceutical product, specifically Pimecrolimus 1% Cream 100GM. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $1,595.16 and a completion date of June 25, 2024. This contract is part of a larger IDC between Amerisourcebergen and DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 9/23/24, 9:59 AM